In dialysis patients, normal homeostasis of both calcium and phosphorus is compromised, resulting to hypercalcemia, hyperphosphatemia, elevated calcium phosphate products, high parathyroid hormone (PTH), and worsen secondary parathyroidism (SHPT) through a direct and indirect mechanism. Here, PTH is linked to hyperphosphatemia.